These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1978978)

  • 1. Double-peaking circadian variation in the occurrence of sustained supraventricular tachyarrhythmias.
    Kupari M; Koskinen P; Leinonen H
    Am Heart J; 1990 Dec; 120(6 Pt 1):1364-9. PubMed ID: 1978978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variation of paroxysmal supraventricular tachycardia.
    Lee SH; Chang PC; Hung HF; Kuan P; Cheng JJ; Hung CR
    Chest; 1999 Mar; 115(3):674-8. PubMed ID: 10084474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of sotalol (Darob) therapy in supraventricular tachyarrhythmias.
    Toporan D; Protopopescu T; Ioan A; Paraschiv A
    Rom J Intern Med; 1998; 36(3-4):207-17. PubMed ID: 10822517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion].
    Delise P; D'Este D; Bonso A; Allibardi P; Raviele A; Di Pede F; Piccolo E
    G Ital Cardiol; 1989 Dec; 19(12):1094-104. PubMed ID: 2576799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol consumption of patients with supraventricular tachyarrhythmias other than atrial fibrillation.
    Koskinen P; Kupari M
    Alcohol Alcohol; 1991; 26(2):199-206. PubMed ID: 1878080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian variation of sustained ventricular tachycardia in patients subject to standard adrenergic blockade.
    Nanthakumar K; Newman D; Paquette M; Greene M; Rakovich G; Dorian P
    Am Heart J; 1997 Oct; 134(4):752-7. PubMed ID: 9351744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Supraventricular tachyarrhythmias during acute myocardial infarction: short- and mid-term clinical significance, therapy and prevention of relapse].
    Berisso MZ; Ferroni A; Molini D; Vecchio C
    G Ital Cardiol; 1991 Jan; 21(1):49-58. PubMed ID: 2055377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Holter monitoring in patients with mitral stenosis and sinus rhythm.
    Ramsdale DR; Arumugam N; Singh SS; Pearson J; Charles RG
    Eur Heart J; 1987 Feb; 8(2):164-70. PubMed ID: 2436916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraventricular tachyarrhythmias: drug therapy versus catheter ablation.
    Scheinman M
    Clin Cardiol; 1994 Sep; 17(9 Suppl 2):II11-5. PubMed ID: 7882608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a long acting beta-adrenoceptor blocker on diurnal variation of cardiac dysrhythmias.
    Mir MA
    Postgrad Med J; 1986 Mar; 62(725):175-8. PubMed ID: 2872664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian pattern of spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
    Eksik A; Akyol A; Norgaz T; Aksu H; Erdinler I; Cakmak N; Alper AT; Cinar B; Yildirim A; Gürkan K
    Med Sci Monit; 2007 Sep; 13(9):CR412-416. PubMed ID: 17767121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients.
    Clair WK; Wilkinson WE; McCarthy EA; Page RL; Pritchett EL
    Circulation; 1993 Apr; 87(4):1114-22. PubMed ID: 8462140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to therapy of supraventricular tachyarrhythmias: an algorithm versus individualized therapy.
    Waldo AL
    Clin Cardiol; 1994 Sep; 17(9 Suppl 2):II21-6. PubMed ID: 7882610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal peak in atrial tachyarrhythmia occurrence as a function of arrhythmia burden.
    Shusterman V; Warman E; London B; Schwartzman D
    J Cardiovasc Electrophysiol; 2012 Jun; 23(6):604-11. PubMed ID: 22429736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ; Anderson JL
    Am J Cardiol; 1996 Aug; 78(4):430-4. PubMed ID: 8752188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
    Honerjäger P; Schmidt G
    Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arrhythmogenic effects of alcohol].
    Krasniqi A; Bostaca I; Dima-Cosma C; Crişu D; Aursulesei V
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1052-6. PubMed ID: 22276445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian pattern of onset of ischaemic and haemorrhagic strokes, and their relation to sleep/wake cycle.
    Butt MU; Zakaria M; Hussain HM
    J Pak Med Assoc; 2009 Mar; 59(3):129-32. PubMed ID: 19288934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Management of Supraventricular Tachyarrhythmias in Patients with Pulmonary Arterial Hypertension.
    Małaczyńska-Rajpold K; Komosa A; Błaszyk K; Araszkiewicz A; Janus M; Olasińska-Wiśniewska A; Jankiewicz S; Mączyński M; Mularek-Kubzdela T
    Heart Lung Circ; 2016 May; 25(5):442-50. PubMed ID: 26643289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.